LONG-TERM SURVIVAL OUTCOMES WITH INTRAVESICAL NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOR RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER AFTER PREVIOUS BACILLUS CALMETTE-GUERIN THERAPY

被引：0
|
作者：
Robins, Dennis J.
Sui, Wilson
Matulay, Justin T.
DeCastro, G. Joel
Anderson, Christopher B.
McKiernan, James M.
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.3263
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP21-01
引用
收藏
页码：E247 / E248
页数：2
相关论文
共 50 条
  • [1] Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non-muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guerin Therapy
    Robins, Dennis J.
    Sui, Wilson
    Matulay, Justin T.
    Ghandour, Rashed
    Anderson, Christopher B.
    DeCastro, G. Joel
    McKiernan, James M.
    [J]. UROLOGY, 2017, 103 : 149 - 153
  • [2] Re: Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Non-Muscle-Invasive Bladder Cancer after Previous bacillus Calmette-Guerin Therapy Editorial Comment
    Chang, Sam S.
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : 665 - 665
  • [3] Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guerin Therapy
    Barlow, LaMont J.
    McKiernan, James M.
    Benson, Mitchell C.
    [J]. JOURNAL OF UROLOGY, 2013, 189 (03): : 834 - 839
  • [4] A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Guerin Refractory Nonmuscle Invasive Bladder Cancer
    McKiernan, James M.
    Barlow, LaMont J.
    Laudano, Melissa A.
    Mann, Mark J.
    Petrylak, Daniel P.
    Benson, Mitchell C.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (02): : 448 - 451
  • [5] Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Bree, K. K.
    Hensley, P. J.
    Brooks, N.
    Matulay, J.
    Navai, N.
    Grossman, H. B.
    Matin, S. F.
    Dinney, C. P.
    Kamat, A. M.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 898 - 898
  • [6] Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule
    Kanuj Malik
    Anand Raja
    Lalgudi Subramaniam Ravishankar
    Kathiresan Narayanaswamy
    Venkatraman Radhakrishnan
    Tenali Gnana Sagar
    [J]. Indian Journal of Surgical Oncology, 2021, 12 : 796 - 801
  • [7] Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule
    Malik, Kanuj
    Raja, Anand
    Ravishankar, Lalgudi Subramaniam
    Narayanaswamy, Kathiresan
    Radhakrishnan, Venkatraman
    Sagar, Tenali Gnana
    [J]. INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (04) : 796 - 801
  • [8] A PHASE 1/2 STUDY OF ALBUMIN-BOUND RAPAMYCIN NANOPARTICLES IN BACILLUS CALMETTE-GUERIN REFRACTORY NON-MUSCLE INVASIVE BLADDER CANCER
    McKiernan, James
    Onyeji, Lfeanyi
    Lascano, Danny
    Ahn, Jennifer
    Holder, Dara
    Abate-Shen, Cory
    RoyChoudhury, Arindham
    Decastro, Guarionex Joel
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E336 - E336
  • [9] Long-term efficacy and safety of intravesical Bacillus Calmette-Guerin Moreau Polish substrain in the treatment of non-muscle invasive bladder cancer
    Bursiewicz, Wiktor
    Zlotkiewicz, Monika
    Krajewski, Wojciech
    Tupikowski, Krzysztof
    Kolodziej, Jan
    Junemann, Rolf
    Mudra, Tobias
    Witecy, Stefanie
    Szydelko, Tomasz
    Kolodziej, Anna
    [J]. CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2024, 77 (02) : 196 - 202
  • [10] Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer
    Sylvester, Richard J.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (02) : 113 - 120
12345